This marks U.S. News & World Report's first-ever evaluation of home health providers nationwide, identifying top-performing ...
Q4 2025 net product revenue for ZORYVE® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product ...
Richard R. Redfern, M.S., C.P.G. No. 10717, an independent Consulting Geologist for Fairchild and a "qualified person" as defined in NI 43-101, has reviewed and approved the scientific and technical ...
FGFs are established as key players during neural induction and also during the induction of ectodermal placodes and possibly the neural crest. FGFs are utilised in the posteriorization of the neural ...